Receiver offering Elona biosimilar insulin patents for $2.2 million
“Buy it now” price good for one week; auction set for September 27 INDIANAPOLIS, IN, USA, September 2, 2013 /EINPresswire.com/ -- A court-appointed receiver for Elona Biotechnologies announced today it was selling the company’s complete portfolio of …